HHS OIG: Institutional Conflicts of Interests at NIH Grantees
The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services (HHS), is the nation’s medical…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Yearly Archives
2011
Shortage of Injection Treatments Looms over ACA
As the Obama Administration and federal agencies begin preparing for implementation of key provisions of the Affordable Care Act…
Risk Evaluation and Mitigation Strategies (REMS) Summary
According to a recent assessment by the Tufts Center for the Study of Drug Development (CSDD), “drug developers, healthcare…
IRS Releases Proposed ACA Fee Structure for Pharmaceutical Medical Device…
With implementation of the new device tax two years away, the Internal Revenue Service (IRS) is trying to determine which devices…
University of Miami Business Forum: The Business of Healthcare –…
The University of Miami Schools of Business and Medicine held the University of Miami Global Business Forum. The event, entitled…
FDA Boot Camp — Hooah
As the regulatory landscape for pharmaceutical and medical device companies continues to rapidly change, and as key provisions of…
Florida Court Overturns Affordable Care Act – The Whole Thing, On the Road…
Today, United States District Judge Roger Vinson ruled that the entire health care overhaul is unconstitutional, but he stopped…
ProPublica Intimidates Denver Area Hospitals and Medical Schools
The latest victim to fall to the irresponsible and questionable journalistic practices of the Pew funded ProPublica was the…
FDA Seeks Input on Transparency Initiative
In June 2009, Food and Drug Administration (FDA) Commissioner Dr. Margaret Hamburg launched FDA’s Transparency Initiative to help…
The Reimbursement Landscape for Novel Diagnostics: Current Limitations,…
The Biotechnology Industry Organization (BIO) recently released a report entitled, “The Reimbursement Landscape for Novel…